We are live on ! Find out more
BG

BlackRock Group Portfolio holdings

AUM $210B
1-Year Est. Return 15.5%
This Fund
S&P 500
This Quarter Est. Return
+0.2%
1 Year Est. Return
+15.5%
3 Year Est. Return
+34.5%
5 Year Est. Return
10 Year Est. Return
AUM
$184B
AUM Growth
-$1.79B
Cap. Flow
-$1.11B
Cap. Flow %
-0.61%
Top 10 Hldgs %
14.47%
Holding
3,020
New
180
Increased
1,664
Reduced
865
Closed
95

Sector Composition

Rank Sector Weight
1 Healthcare 16.47%
2 Financials 14.48%
3 Technology 13.64%
4 Industrials 8.61%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGII icon
2626
Digi International
DGII
$2.52B
$148K ﹤0.01%
15,541
+3,545
+30% +$34.6K
TVRD
2627
Tvardi Therapeutics
TVRD
$23.5M
$148K ﹤0.01%
+338
New +$131K
QLTY
2628
DELISTED
QUALITY DISTR INC FLA
QLTY
$148K ﹤0.01%
9,554
-18,244
-66% -$246K
HK
2629
DELISTED
Halcon Resources Corporation
HK
$147K ﹤0.01%
738
+86
+13% +$20.5K
PRO
2630
DELISTED
PROS Holdings
PRO
$146K ﹤0.01%
6,951
+4,376
+170% +$95.4K
RCKY icon
2631
Rocky Brands
RCKY
$304M
$146K ﹤0.01%
7,808
TRC icon
2632
Tejon Ranch
TRC
$476M
$146K ﹤0.01%
5,847
+2,795
+92% +$68.6K
NVRO
2633
DELISTED
NEVRO CORP.
NVRO
$146K ﹤0.01%
2,708
+346
+15% +$17.6K
WWE
2634
DELISTED
World Wrestling Entertainment
WWE
$146K ﹤0.01%
8,866
+1,600
+22% +$23.2K
CTRN icon
2635
Citi Trends
CTRN
$524M
$145K ﹤0.01%
+5,994
New +$148K
TAL icon
2636
TAL Education Group
TAL
$5.71B
$145K ﹤0.01%
24,690
-22,080
-47% -$134K
AXDX
2637
DELISTED
Accelerate Diagnostics
AXDX
$144K ﹤0.01%
561
+416
+287% +$99.3K
PRTK
2638
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$144K ﹤0.01%
+5,570
New +$158K
ZEN
2639
DELISTED
ZENDESK INC
ZEN
$144K ﹤0.01%
6,483
+1,750
+37% +$40.2K
MTSI icon
2640
MACOM Technology Solutions
MTSI
$20.4B
$143K ﹤0.01%
3,727
+1,000
+37% +$36.9K
LOXO
2641
DELISTED
Loxo Oncology, Inc
LOXO
$143K ﹤0.01%
7,924
+1,802
+29% +$24.6K
EHTH icon
2642
eHealth
EHTH
$42.5M
$142K ﹤0.01%
11,199
-6,880
-38% -$83.2K
ZSPH
2643
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$141K ﹤0.01%
2,695
+725
+37% +$35.7K
CPHR
2644
DELISTED
Cipher Pharmaceuticals Inc.
CPHR
$140K ﹤0.01%
16,317
MTL
2645
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$139K ﹤0.01%
56,340
-7,228
-11% -$18.8K
SQI
2646
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
$138K ﹤0.01%
9,313
+4,820
+107% +$75.4K
VHI icon
2647
Valhi
VHI
$385M
$137K ﹤0.01%
2,015
LDRH
2648
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$137K ﹤0.01%
3,179
+1,785
+128% +$70.9K
BELFB
2649
Bel Fuse Inc Class B
BELFB
$3.88B
$136K ﹤0.01%
6,635
+1,512
+30% +$31.2K
SGYP
2650
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$136K ﹤0.01%
+16,437
New +$79.7K

Similar funds

BlackRock Group's Q2 2015 Portfolio in Review

As of Q2 2015, BlackRock Group held 3,020 positions worth $184B, down 0.97% from $186B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Group's Q2 2015 filing shows 180 new, 1,664 increased, 865 reduced and 95 closed positions. Its largest new stake was Jazz Pharmaceuticals: 396,108 shares worth $69.7M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $884M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

  • BlackRock Group's largest Q2 2015 buy was Jazz Pharmaceuticals: 396,108 shares worth $69.7M.
  • BlackRock Group added most to iShares MSCI Taiwan ETF in Q2 2015, an estimated $173M increase.
  • BlackRock Group's biggest Q2 2015 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $884M.
  • BlackRock Group fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $192M.
  • BlackRock Group's ten largest holdings make up 14% of its $184B portfolio in Q2 2015.
  • BlackRock Group opened 180 new positions and closed 95 in Q2 2015.
  • BlackRock Group's portfolio value fell 0.97% quarter-over-quarter to $184B.

Based on BlackRock Group's 13F filing for Q2 2015, filed 7 Aug 2015.